Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response
- PMID: 22654100
- PMCID: PMC3408198
- DOI: 10.1074/jbc.M112.367672
Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response
Abstract
Francisella tularensis, the causative agent of tularemia, is one of the deadliest agents of biological warfare and bioterrorism. Extremely high virulence of this bacterium is associated with its ability to dampen or subvert host innate immune response. The objectives of this study were to identify factors and understand the mechanisms of host innate immune evasion by F. tularensis. We identified and explored the pathogenic role of a mutant interrupted at gene locus FTL_0325, which encodes an OmpA-like protein. Our results establish a pathogenic role of FTL_0325 and its ortholog FTT0831c in the virulent F. tularensis SchuS4 strain in intramacrophage survival and suppression of proinflammatory cytokine responses. This study provides mechanistic evidence that the suppressive effects on innate immune responses are due specifically to these proteins and that FTL_0325 and FTT0831c mediate immune subversion by interfering with NF-κB signaling. Furthermore, FTT0831c inhibits NF-κB activity primarily by preventing the nuclear translocation of p65 subunit. Collectively, this study reports a novel F. tularensis factor that is required for innate immune subversion caused by this deadly bacterium.
Figures
Similar articles
-
Contributions of TolC Orthologs to Francisella tularensis Schu S4 Multidrug Resistance, Modulation of Host Cell Responses, and Virulence.Infect Immun. 2019 Mar 25;87(4):e00823-18. doi: 10.1128/IAI.00823-18. Print 2019 Apr. Infect Immun. 2019. PMID: 30670554 Free PMC article.
-
Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.mBio. 2013 Feb 12;4(1):e00638-12. doi: 10.1128/mBio.00638-12. mBio. 2013. PMID: 23404403 Free PMC article.
-
Repression of inflammasome by Francisella tularensis during early stages of infection.J Biol Chem. 2013 Aug 16;288(33):23844-57. doi: 10.1074/jbc.M113.490086. Epub 2013 Jul 2. J Biol Chem. 2013. PMID: 23821549 Free PMC article.
-
Innate Immune Recognition: An Issue More Complex Than Expected.Front Cell Infect Microbiol. 2019 Jul 3;9:241. doi: 10.3389/fcimb.2019.00241. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31334134 Free PMC article. Review.
-
Uncovering the components of the Francisella tularensis virulence stealth strategy.Front Cell Infect Microbiol. 2014 Mar 7;4:32. doi: 10.3389/fcimb.2014.00032. eCollection 2014. Front Cell Infect Microbiol. 2014. PMID: 24639953 Free PMC article. Review.
Cited by
-
Francisella tularensis Glyceraldehyde-3-Phosphate Dehydrogenase Is Relocalized during Intracellular Infection and Reveals Effect on Cytokine Gene Expression and Signaling.Cells. 2023 Feb 13;12(4):607. doi: 10.3390/cells12040607. Cells. 2023. PMID: 36831274 Free PMC article.
-
Identification of pyrC gene as an immunosuppressive factor in Francisella novicida infection.Front Cell Infect Microbiol. 2022 Oct 26;12:1027424. doi: 10.3389/fcimb.2022.1027424. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36389167 Free PMC article.
-
Nlrp3 Increases the Host's Susceptibility to Tularemia.Front Microbiol. 2021 Oct 6;12:725572. doi: 10.3389/fmicb.2021.725572. eCollection 2021. Front Microbiol. 2021. PMID: 34690967 Free PMC article.
-
An AraC/XylS Family Transcriptional Regulator Modulates the Oxidative Stress Response of Francisella tularensis.J Bacteriol. 2021 Nov 5;203(23):e0018521. doi: 10.1128/JB.00185-21. Epub 2021 Sep 20. J Bacteriol. 2021. PMID: 34543107 Free PMC article.
-
Transcriptomic and Metabolic Responses to a Live-Attenuated Francisella tularensis Vaccine.Vaccines (Basel). 2020 Jul 24;8(3):412. doi: 10.3390/vaccines8030412. Vaccines (Basel). 2020. PMID: 32722194 Free PMC article.
References
-
- Oyston P. C., Sjostedt A., Titball R. W. (2004) Tularemia. Bioterrorism defense renews interest in Francisella tularensis. Nat. Rev. Microbiol. 2, 967–978 - PubMed
-
- Tärnvik A., Priebe H. S., Grunow R. (2004) Tularemia in Europe. An epidemiological overview. Scand. J. Infect. Dis. 36, 350–355 - PubMed
-
- Dennis D. T., Inglesby T. V., Henderson D. A., Bartlett J. G., Ascher M. S., Eitzen E., Fine A. D., Friedlander A. M., Hauer J., Layton M., Lillibridge S. R., McDade J. E., Osterholm M. T., O'Toole T., Parker G., Perl T. M., Russell P. K., Tonat K. (2001) Tularemia as a biological weapon. Medical and public health management. JAMA 285, 2763–2773 - PubMed
-
- Gallagher-Smith M., Kim J., Al-Bawardy R., Josko D. (2004) Francisella tularensis. Possible agent in bioterrorism. Clin. Lab. Sci. 17, 35–39 - PubMed
-
- Saslaw S., Eigelsbach H. T., Prior J. A., Wilson H. E., Carhart S. (1961) Tularemia vaccine study. II. Respiratory challenge. Arch. Intern. Med. 107, 702–714 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
